{
	"edges": {
		"7cc5e996d11f4690-9": {
			"id": "7cc5e996d11f4690-9",
			"source": "7cc5e996d11f4690-2",
			"target": "7cc5e996d11f4690-8"
		},
		"7cc5e996d11f4690-11": {
			"id": "7cc5e996d11f4690-11",
			"source": "7cc5e996d11f4690-8",
			"target": "7cc5e996d11f4690-10"
		},
		"7cc5e996d11f4690-12": {
			"id": "7cc5e996d11f4690-12",
			"source": "7cc5e996d11f4690-10",
			"target": "7cc5e996d11f4690-5"
		},
		"7cc5e996d11f4690-14": {
			"id": "7cc5e996d11f4690-14",
			"source": "7cc5e996d11f4690-5",
			"target": "7cc5e996d11f4690-4"
		},
		"7cc5e996d11f4690-15": {
			"id": "7cc5e996d11f4690-15",
			"source": "7cc5e996d11f4690-5",
			"target": "7cc5e996d11f4690-13"
		},
		"3e42e220473accdb-2": {
			"id": "3e42e220473accdb-2",
			"source": "7cc5e996d11f4690-4",
			"target": "7cc5e996d11f4690-3"
		},
		"5ff13e917858c552-2": {
			"id": "5ff13e917858c552-2",
			"source": "7cc5e996d11f4690-17",
			"target": "3e42e220473accdb-1"
		},
		"4785f901812f39dc-1": {
			"id": "4785f901812f39dc-1",
			"source": "7cc5e996d11f4690-13",
			"target": "7cc5e996d11f4690-17"
		}
	},
	"nodes": {
		"0": {
			"id": "0",
			"value": null,
			"shape": null,
			"fillColor": null,
			"type": "normalNode",
			"edges": {
				"in": [],
				"out": []
			}
		},
		"1": {
			"id": "1",
			"value": null,
			"shape": null,
			"fillColor": null,
			"type": "normalNode",
			"edges": {
				"in": [],
				"out": []
			}
		},
		"7cc5e996d11f4690-1": {
			"id": "7cc5e996d11f4690-1",
			"value": "Stepwise Considerations for Apixaban (Eliquis速) Reversal",
			"valueAsHtml": "Stepwise Considerations for Apixaban (Eliquis<span><sup>速</sup></span>) Reversal",
			"shape": null,
			"fillColor": null,
			"type": "normalNode",
			"edges": {
				"in": [],
				"out": []
			}
		},
		"7cc5e996d11f4690-3": {
			"id": "7cc5e996d11f4690-3",
			"value": "- Ingested within 3 hrs: activated charcoal- Prothombin Complex Concentrate\n(PCC) is NOT indicated",
			"valueAsHtml": "<span>- Ingested within 3 hrs: activated charcoal&nbsp;</span><div><span>- Prothombin Complex Concentrate (PCC) is NOT indicated</span><br></div>",
			"shape": null,
			"fillColor": "#FF8A80",
			"type": "normalNode",
			"edges": {
				"in": [
					"3e42e220473accdb-2"
				],
				"out": []
			}
		},
		"7cc5e996d11f4690-4": {
			"id": "7cc5e996d11f4690-4",
			"value": "Mild-Moderate Bleeding",
			"valueAsHtml": "Mild-Moderate Bleeding</div>",
			"shape": null,
			"fillColor": "#E1BEE7",
			"type": "normalNode",
			"edges": {
				"in": [
					"7cc5e996d11f4690-14"
				],
				"out": [
					"3e42e220473accdb-2"
				]
			}
		},
		"7cc5e996d11f4690-5": {
			"id": "7cc5e996d11f4690-5",
			"value": "What level?",
			"valueAsHtml": "What level?",
			"shape": "hexagon",
			"fillColor": "#82B1FF",
			"type": "normalNode",
			"edges": {
				"in": [
					"7cc5e996d11f4690-12"
				],
				"out": [
					"7cc5e996d11f4690-14",
					"7cc5e996d11f4690-15"
				]
			}
		},
		"7cc5e996d11f4690-8": {
			"id": "7cc5e996d11f4690-8",
			"value": "Discontinue Apixaban",
			"valueAsHtml": "Discontinue Apixaban",
			"shape": null,
			"fillColor": "#8BCCA5",
			"type": "normalNode",
			"edges": {
				"in": [
					"7cc5e996d11f4690-9"
				],
				"out": [
					"7cc5e996d11f4690-11"
				]
			}
		},
		"7cc5e996d11f4690-10": {
			"id": "7cc5e996d11f4690-10",
			"value": "Type and Screen STAT Supportive Care",
			"valueAsHtml": "Type and Screen STAT Supportive Care",
			"shape": null,
			"fillColor": "#8BCCA5",
			"type": "normalNode",
			"edges": {
				"in": [
					"7cc5e996d11f4690-11"
				],
				"out": [
					"7cc5e996d11f4690-12"
				]
			}
		},
		"7cc5e996d11f4690-13": {
			"id": "7cc5e996d11f4690-13",
			"value": "Severe-Life Threatening Bleeding or Emergent Reversal",
			"valueAsHtml": "<div><br></div>Severe-Life Threatening Bleeding or Emergent Reversal</div>",
			"shape": null,
			"fillColor": "#E1BEE7",
			"type": "normalNode",
			"edges": {
				"in": [
					"7cc5e996d11f4690-15"
				],
				"out": [
					"4785f901812f39dc-1"
				]
			}
		},
		"7cc5e996d11f4690-17": {
			"id": "7cc5e996d11f4690-17",
			"value": "- Ingested within 3 hrs: activated charcoal- Prothombin Complex Concentrate\n(PCC) 50 units/kg IV Pushx1dose (dose rounded per P&T protocol)",
			"valueAsHtml": "<span>- Ingested within 3 hrs: activated charcoal&nbsp;</span><div><span>- Prothombin Complex Concentrate (PCC) 50 units/kg IV Pushx1dose (dose rounded per P&amp;T protocol)</span><br></div>",
			"shape": null,
			"fillColor": "#8BCCA5",
			"type": "normalNode",
			"edges": {
				"in": [
					"4785f901812f39dc-1"
				],
				"out": [
					"5ff13e917858c552-2"
				]
			}
		},
		"3e42e220473accdb-1": {
			"id": "3e42e220473accdb-1",
			"value": "Obtain the following labs at baseline and Q6H x 36H for coagulopathy\nmonitoring:  - aPTT, PT- R time on TEG (if available)",
			"valueAsHtml": "<div>Obtain the following labs at baseline and Q6H x 36H for coagulopathy monitoring:&nbsp;</div><div>- aPTT, PT</div><div>- R time on TEG (if available)&nbsp;</div>",
			"shape": null,
			"fillColor": "#FF8A80",
			"type": "normalNode",
			"edges": {
				"in": [
					"5ff13e917858c552-2"
				],
				"out": []
			}
		},
		"1b62c285d5db8e15-1": {
			"id": "1b62c285d5db8e15-1",
			"value": null,
			"valueAsHtml": "",
			"shape": null,
			"fillColor": null,
			"type": "normalNode",
			"edges": {
				"in": [],
				"out": []
			}
		},
		"330e3e25cd77550e-4": {
			"id": "330e3e25cd77550e-4",
			"value": "Time to Peak2-4 hrsHalf Life8-15 hrsMetabolismHepatic mainly via CYP3A4/5,\nsubstrate of P-glycoprotein and CYP2J@EliminationUrine: -27% as parent drug:\nfeces: majorityEffect on aPTT/PTPresence of drug can increase measurement in a\nconcentration dependent manor",
			"valueAsHtml": "<table border=\"1\" width=\"100%\" style=\"text-align: center ; width: 100% ; height: 100% ; border-collapse: collapse\"><tbody><tr><td align=\"center\"><b>Time to Peak</b></td><td align=\"center\">2-4 hrs</td></tr><tr><td align=\"center\"><b>Half Life</b></td><td align=\"center\">8-15 hrs</td></tr><tr><td style=\"text-align: center\"><b>Metabolism</b></td><td style=\"text-align: center\">Hepatic mainly via CYP3A4/5, substrate of P-glycoprotein and CYP2J@</td></tr><tr><td style=\"text-align: center\"><b>Elimination</b></td><td>Urine: -27% as parent drug: feces: majority</td></tr><tr><td align=\"center\"><b>Effect on aPTT/PT</b></td><td align=\"center\">Presence of drug can increase measurement in a concentration dependent manor</td></tr></tbody></table>",
			"shape": null,
			"fillColor": "#fff2cc",
			"type": "normalNode",
			"edges": {
				"in": [],
				"out": []
			}
		},
		"330e3e25cd77550e-5": {
			"id": "330e3e25cd77550e-5",
			"value": "Apixaban (Eliquis速)",
			"valueAsHtml": "<table><tbody><tr><td>Apixaban (Eliquis<sup>速)</sup></td></tr></tbody></table><br>",
			"shape": null,
			"fillColor": "none",
			"type": "normalNode",
			"edges": {
				"in": [],
				"out": []
			}
		},
		"2d7246893fd4f598-1": {
			"id": "2d7246893fd4f598-1",
			"value": "*",
			"valueAsHtml": "<font style=\"font-size: 25px\"><sub>*</sub></font>",
			"shape": null,
			"fillColor": "none",
			"type": "normalNode",
			"edges": {
				"in": [],
				"out": []
			}
		},
		"2d7246893fd4f598-2": {
			"id": "2d7246893fd4f598-2",
			"value": "*No current recommendations for apixaban, the following info is inferred from\nrivaroxaban data",
			"valueAsHtml": "<font style=\"font-size: 25px\">*</font>No current recommendations for apixaban, the following info is inferred from rivaroxaban data&nbsp;",
			"shape": "note",
			"fillColor": "#fff2cc",
			"type": "normalNode",
			"edges": {
				"in": [],
				"out": []
			}
		},
		"5ff13e917858c552-3": {
			"id": "5ff13e917858c552-3",
			"value": "**",
			"valueAsHtml": "<font style=\"font-size: 25px\"><sub>**</sub></font>",
			"shape": null,
			"fillColor": "none",
			"type": "normalNode",
			"edges": {
				"in": [],
				"out": []
			}
		},
		"5ff13e917858c552-4": {
			"id": "5ff13e917858c552-4",
			"value": "**",
			"valueAsHtml": "<font style=\"font-size: 25px\"><sub>**</sub></font>",
			"shape": null,
			"fillColor": "none",
			"type": "normalNode",
			"edges": {
				"in": [],
				"out": []
			}
		},
		"5ff13e917858c552-5": {
			"id": "5ff13e917858c552-5",
			"value": "**Happens simulatneously",
			"valueAsHtml": "<font style=\"font-size: 25px\">**</font>Happens simulatneously&nbsp;",
			"shape": "note",
			"fillColor": "#fff2cc",
			"type": "normalNode",
			"edges": {
				"in": [],
				"out": []
			}
		},
		"7cc5e996d11f4690-2": {
			"id": "7cc5e996d11f4690-2",
			"value": null,
			"shape": "startState",
			"fillColor": "#424242",
			"type": "decisionPoint",
			"edges": {
				"in": [],
				"out": [
					"7cc5e996d11f4690-9"
				]
			}
		}
	}
}